Literature DB >> 1825619

Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants.

C Schreiner1, M Fisher, S Hussein, R L Juliano.   

Abstract

We have developed a series of variant clonal Chinese hamster ovary cell sublines which are deficient in the expression of the alpha 5/beta 1 integrin fibronectin receptor. When these clonal sublines were injected s.c. into nude mice, there were marked differences in the rate of tumor growth. Tumors from clones expressing very low levels of fibronectin receptor grew most rapidly, clones expressing levels of fibronectin receptor comparable to wild type cells grew at an intermediate rate, while a clone expressing elevated levels of fibronectin receptor grew slowly. Cells recovered from the tumors maintained their original phenotypes in terms of levels of fibronectin receptor expression. These results suggest that there is an inverse correlation between the level of expression of the alpha 5/beta 1 fibronectin receptor and the rate of tumor growth.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825619

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  42 in total

1.  alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway.

Authors:  J W Lee; R L Juliano
Journal:  Mol Biol Cell       Date:  2000-06       Impact factor: 4.138

2.  Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials.

Authors:  S J Prest; R C Rees; C Murdoch; J F Marshall; P A Cooper; M Bibby; G Li; S A Ali
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

3.  Spatiotemporal image correlation spectroscopy (STICS) theory, verification, and application to protein velocity mapping in living CHO cells.

Authors:  Benedict Hebert; Santiago Costantino; Paul W Wiseman
Journal:  Biophys J       Date:  2005-02-18       Impact factor: 4.033

4.  Regulation of keratin and integrin gene expression in cancer and drug resistance.

Authors:  N Daly; P Meleady; D Walsh; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

5.  The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression.

Authors:  Z Zhang; K Vuori; J C Reed; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

6.  Regulation and function of an activation-dependent epitope of the beta 1 integrins in vascular cells after balloon injury in baboon arteries and in vitro.

Authors:  N Koyama; J Seki; S Vergel; E J Mattsson; T Yednock; N L Kovach; J M Harlan; A W Clowes
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

7.  Expression of the integrin alpha5 subunit and its mediated cell adhesion in hepatocellular carcinoma.

Authors:  M Yao; X D Zhou; X L Zha; D R Shi; J Fu; J Y He; H F Lu; Z Y Tang
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

8.  Fibronectin is chemotactic for CT 26 colon carcinoma cells: sub-lines selected for increased chemotaxis to fibronectin display decreased tumorigenicity and lung colonization.

Authors:  L Geng; S A Ali; J F Marshall; C L Mackay; I R Hart; M Delcommence; C H Streuli; R C Rees
Journal:  Clin Exp Metastasis       Date:  1998-11       Impact factor: 5.150

9.  Integrin alpha5beta1: a potent inhibitor of experimental lung metastasis.

Authors:  M Schirner; F Herzberg; R Schmidt; M Streit; M Schöning; M Hummel; C Kaufmann; E Thiel; E D Kreuser
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

10.  The tumor microenvironment: possible role of integrins and the extracellular matrix in tumor biological behavior of intratubular germ cell neoplasia and testicular seminomas.

Authors:  A Timmer; J W Oosterhuis; H Schraffordt Koops; D T Sleijfer; B G Szabo; W Timens
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.